2016
DOI: 10.1111/vco.12200
|View full text |Cite
|
Sign up to set email alerts
|

Melting curve analysis in canine lymphoma by calculating maximum fluorescence decrease

Abstract: PARR is widely used in the diagnostics of canine lymphoma. In human and veterinary medicine, melting curve analysis (MCA) has successfully been introduced to facilitate the process. Since visual interpretation of melting curves can be rather subjective, the purpose of this study was to develop an objective interpretation of melting curves by calculating the maximum fluorescence decrease (dF ) within a defined rise of temperature. Lymph node aspirates and blood of 34 dogs with lymphoma and 28 control dogs were … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
5
0

Year Published

2017
2017
2021
2021

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(6 citation statements)
references
References 39 publications
(118 reference statements)
1
5
0
Order By: Relevance
“…The positive result was confirmed with repeat testing at CSU. The sensitivity of our assay falls within that reported for similar primer sets in other studies (57, 10, 20). …”
Section: Methodssupporting
confidence: 88%
See 4 more Smart Citations
“…The positive result was confirmed with repeat testing at CSU. The sensitivity of our assay falls within that reported for similar primer sets in other studies (57, 10, 20). …”
Section: Methodssupporting
confidence: 88%
“…Clonal rearrangements in both B and T cell receptors have been reported in dogs with lymphoid neoplasms; however, the proportion of biclonality in dogs with AML is higher than that reported for dogs with lymphoid neoplasia, which ranges from 1 to 10% (3, 5, 6, 10). These data indicate that if clonality testing is done in a dog with acute leukemia of unclear phenotype, a B and T cell biclonal result should raise the index of suspicion for an underlying AML and prompt further testing for AML, such as expanded testing for myeloid antigen expression on flow cytometric analysis or cytochemical staining.…”
Section: Discussionmentioning
confidence: 79%
See 3 more Smart Citations